All In Biotech

Free tool

FAERS Monitor: Botox Cosmetic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103000 or its brand name (Botox Cosmetic, Onabotulinumtoxina). Reports on generic versions are filed under their own applications.

Reports

77,970

Serious

15,443

20% of reports

Hospitalization

4,780

Death reported

2,225

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective26,774
  • off label use11,721
  • therapeutic response decreased4,513
  • headache4,135
  • product preparation error3,646
  • injection site pain3,468
  • eyelid ptosis3,149
  • multiple use of single-use product2,866
  • migraine2,406
  • nausea2,245
  • pain1,921
  • fatigue1,878
  • muscular weakness1,820
  • dizziness1,813
  • dysphagia1,731

Reports by year received

View as table
YearReports
2004102
2005102
2006110
2007146
2008454
2009341
20104,860
20111,455
20122,710
20133,065
20143,096
20153,398
20164,998
20174,233
20184,692
20196,167
20205,224
20215,623
20225,185
20237,533
20245,357
20255,319
20263,800

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,189 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple use of single-use productSignal2,866280.0265.8390,365
eyelid ptosisSignal3,149120.6115.7257,975
product preparation errorSignal3,64658.056.0168,063
therapeutic response decreasedSignal4,51321.621.082,340
migraineSignal2,4066.96.711,993
drug ineffectiveSignal26,7745.65.5105,004
dysphagiaSignal1,7315.04.85,445
muscular weaknessSignal1,8204.44.24,682
off label useSignal11,7213.63.623,172
injection site painSignal3,4683.13.04,865
headache4,1351.81.71,459
dizziness1,8131.00.91
pain1,9210.80.857
nausea2,2450.80.7168
fatigue1,8780.60.6367

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.